L-159913

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameL-159913
Drug Alias NameL-159 913
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin I antagonists
TargetsAngiotensin I
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A